Resultados de la búsqueda 61-70 of 13047 for B cell lymphomas
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Numeración de páginas Estudios clínicos.
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas.
Epcoritamab (Epkinly) and glofitamab (Columvi) also target CD3 and CD20 to treat diffuse large B-cell lymphoma (DLBCL) and related lymphomas. Solid tumors.
Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. ... B-cell lymphoma 2 (BCL2) inhibitor. A Study To ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Aggressive Malignancy PDX (Avatar) and ...
B-cell non-Hodgkin lymphomas. The Lancet. 2024; doi:10.1016/S0140-6736(23)02705-8. NHL subtypes. Leukemia & Lymphoma Society. https://www.lls.org/lymphoma ...
... B-Cell Lymphoma (DLBCL). A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?